Answer
Zoladex 3.6 mg (goserelin acetate) is indicated for oestrogen receptor (ER)-positive early and advanced breast cancer in pre- and perimenopausal women.
Sources for this answer
- Zoladex 3.6mg ImplantAstraZeneca UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 20Document updated
Sources checked